A comprehensive view of Rx-to-OTC Switch. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA states 4 mg naloxone nasal spray and 2 mg intramuscular autoinjector delivery overdose reversal med formats may be approvable for OTC use; FDA singled out Kaleo’s Evzio prefilled autoinjector, Emergent BioSolutions' Narca nasal spray as candidates

Over 77% of reproductive-aged women support prescription-free OTC birth control pills because of convenience; studies suggest OTC birth control would increase use of contraception, facilitate continuity of use: Kaiser Family Foundation

FDA postpones decision date regarding whether to allow OTC sales of Perrigo’s prescription Opill birth control drug by 90 days; decision was originally scheduled for first half of 2023

Fitch: New FDA ruling that creates new category of OTC hearing aids in US will significantly expand access; total hearing aids market expected to expand at 2021-2026 CAGR of 4.2%, making it among fastest growing sub-categories in wider patient aids market

FDA approves the sale of OTC hearing aids starting in mid-October without a medical exam, prescription or audiologist fitting, which White House says will save consumers US$2,800 per pair; 38 million in US have mild to moderate hearing loss

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count